Stepan (SCL) Aperçu de l'action
Stepan Company, ainsi que ses filiales, produit et vend des spécialités chimiques et des produits chimiques intermédiaires à d'autres fabricants qui les utilisent dans divers produits finis aux États-Unis, en France, en Pologne, au Royaume-Uni, au Brésil, au Mexique et dans le monde entier. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 5/6 |
| Croissance future | 3/6 |
| Performances passées | 0/6 |
| Santé financière | 3/6 |
| Dividendes | 3/6 |
Récompenses
Analyse des risques
SCL Community Fair Values
Create NarrativeSee what 8 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Stepan Company Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | US$58.94 |
| Plus haut sur 52 semaines | US$68.00 |
| Plus bas sur 52 semaines | US$41.82 |
| Bêta | 0.95 |
| Variation sur 1 mois | 10.17% |
| Variation sur 3 mois | 13.85% |
| Variation sur 1 an | 1.99% |
| Variation sur 3 ans | -36.80% |
| Variation sur 5 ans | -50.07% |
| Évolution depuis l'introduction en bourse | 10,873.56% |
Nouvelles et mises à jour récentes
Seeking Alpha • Jul 10
Stepan Company's Discount Isn't Over Yet
Summary Stepan Company remains a 'buy' due to attractive valuation, despite recent underperformance versus the S&P 500. Recent results show mixed fundamentals: revenue growth driven by Surfactants, but profitability pressured by restructuring charges and raw material costs. Project Catalyst targets $100 million in pre-tax cost savings over two years, with 60% expected this year and the remainder next. SCL’s strategy focuses on expanding share in large, growing addressable markets across Surfactants and Polymers, supporting long-term upside. Read the full article on Seeking Alpha
Mise à jour du récit • Jun 18
SCL: Stable Margins And Outlook Will Support Long-Term Dividend Upside
Analysts have kept their Stepan price target steady at $75, citing largely unchanged assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E as the basis for this reaffirmed view. What’s in the News for Stepan No recent Stepan news items were identified in the provided primary news source.Mise à jour du récit • Jun 04
SCL: Higher Margins And Revenue Outlook Will Support Long-Term Dividend Upside
Analysts have raised their price target for Stepan to $75.00, with the shift supported by updated assumptions for slightly lower discount rates, expectations of higher revenue, stronger profit margins, and a reduced future P/E multiple. What's in the News No recent company specific news items, periodical coverage, or key developments were provided for Stepan in the supplied sources.Recent updates
Seeking Alpha • Jul 10
Stepan Company's Discount Isn't Over Yet
Summary Stepan Company remains a 'buy' due to attractive valuation, despite recent underperformance versus the S&P 500. Recent results show mixed fundamentals: revenue growth driven by Surfactants, but profitability pressured by restructuring charges and raw material costs. Project Catalyst targets $100 million in pre-tax cost savings over two years, with 60% expected this year and the remainder next. SCL’s strategy focuses on expanding share in large, growing addressable markets across Surfactants and Polymers, supporting long-term upside. Read the full article on Seeking AlphaMise à jour du récit • Jun 18
SCL: Stable Margins And Outlook Will Support Long-Term Dividend Upside
Analysts have kept their Stepan price target steady at $75, citing largely unchanged assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E as the basis for this reaffirmed view. What’s in the News for Stepan No recent Stepan news items were identified in the provided primary news source.Mise à jour du récit • Jun 04
SCL: Higher Margins And Revenue Outlook Will Support Long-Term Dividend Upside
Analysts have raised their price target for Stepan to $75.00, with the shift supported by updated assumptions for slightly lower discount rates, expectations of higher revenue, stronger profit margins, and a reduced future P/E multiple. What's in the News No recent company specific news items, periodical coverage, or key developments were provided for Stepan in the supplied sources.Mise à jour du récit • Apr 28
SCL: Stable Margins And Buybacks Will Support Long-Term Dividend Upside
Analysts kept their fair value estimate steady at $75, with only marginal tweaks to the discount rate, revenue growth, profit margin, and future P/E assumptions. This indicates a largely unchanged view of Stepan's longer term potential.Mise à jour du récit • Apr 12
SCL: Stable Margins And Buyback Completion Will Support Long-Term Dividend Upside
Analysts have nudged their Stepan price target slightly higher to $75.00, with modest tweaks to the discount rate and P/E assumptions supporting this updated view. What's in the News For the three months ended December 31, 2025, Stepan Company reported unaudited goodwill impairment of $6,245,000, which directly affects reported earnings quality for that period (Key Developments).Mise à jour du récit • Mar 28
SCL: Steady Fair Value And Margins Will Support Long-Term Dividend Upside
Analysts have maintained their Stepan fair value estimate at $75.00, making only small adjustments to the discount rate, revenue growth, profit margin and future P/E assumptions. This signals that their overall view on the stock’s longer-term potential remains largely unchanged.Mise à jour du récit • Mar 14
SCL: Steady Fair Value And Margins Will Support Long-Term Dividend Upside
Analysts have modestly revised their price outlook for Stepan, keeping fair value around $75.00 while making small tweaks to the discount rate and projected P/E. This reflects updated assumptions about the risk profile and valuation multiples rather than a shift in the underlying growth or margin view.Mise à jour du récit • Feb 27
SCL: Higher Future P/E Assumptions Will Support Long-Term Dividend Upside
Analysts have adjusted their Stepan price target to $75.00, with the change tied to updated views on discount rate, revenue growth, profit margin, and a higher assumed future P/E multiple. What's in the News Stepan Company reported an unaudited goodwill impairment of $6,245,000 for the three months ended December 31, 2025.Mise à jour du récit • Feb 11
SCL: Refined Discount Rate Assumptions Will Support Long-Term Dividend Upside
Analysts have kept their Stepan price target steady at $75.00, citing only slight tweaks to assumptions like discount rate, revenue growth, profit margin, and future P/E that were not material enough to change their overall valuation view. Valuation Changes Fair Value: Steady at $75.00, indicating no change in the analysts' central valuation estimate.Article d’analyse • Feb 04
Why Investors Shouldn't Be Surprised By Stepan Company's (NYSE:SCL) 26% Share Price Surge
Despite an already strong run, Stepan Company ( NYSE:SCL ) shares have been powering on, with a gain of 26% in the last...Mise à jour du récit • Jan 27
SCL: Higher Discount Rate Will Set Up Attractive Long-Term Dividend Returns
Analysts now estimate Stepan's fair value at US$75.00, reduced from US$82.21. This change reflects updated assumptions regarding a higher discount rate, revised profit margin expectations, a slightly higher revenue growth outlook, and a lower future P/E multiple.Article d’analyse • Jan 08
Stepan (NYSE:SCL) May Have Issues Allocating Its Capital
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...Article d’analyse • Dec 12
Why Stepan Company (NYSE:SCL) Could Be Worth Watching
Stepan Company ( NYSE:SCL ), is not the largest company out there, but it saw a double-digit share price rise of over...Article d’analyse • Nov 04
Stepan (NYSE:SCL) Will Pay A Larger Dividend Than Last Year At $0.395
Stepan Company's ( NYSE:SCL ) periodic dividend will be increasing on the 15th of December to $0.395, with investors...Article d’analyse • Sep 04
Here's What's Concerning About Stepan's (NYSE:SCL) Returns On Capital
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...Article d’analyse • Jul 31
Is It Time To Consider Buying Stepan Company (NYSE:SCL)?
While Stepan Company ( NYSE:SCL ) might not have the largest market cap around , it received a lot of attention from a...Article d’analyse • Jun 10
Earnings Tell The Story For Stepan Company (NYSE:SCL)
Stepan Company's ( NYSE:SCL ) price-to-earnings (or "P/E") ratio of 22.5x might make it look like a sell right now...Article d’analyse • May 02
Results: Stepan Company Exceeded Expectations And The Consensus Has Updated Its Estimates
A week ago, Stepan Company ( NYSE:SCL ) came out with a strong set of first-quarter numbers that could potentially lead...Seeking Alpha • Apr 20
Stepan Company's Plunge Offers Investors A Chance To Clean Up
Summary Markets are inefficient short-term, creating opportunities for logical, value-oriented investors; Stepan Company is now a ‘buy’ due to recent price drops and management's positive outlook. Despite a 6% revenue drop in 2024, Stepan Company improved net income and EBITDA, driven by cost-cutting measures and productivity improvements. Management is optimistic about 2025, expecting volume growth, margin improvement, and positive free cash flow, targeting high-margin, growth-oriented markets. Analysts forecast revenue and earnings growth for Q1 2025; shares are attractively priced compared to peers, justifying an upgrade to a ‘buy’ rating. Read the full article on Seeking AlphaArticle d’analyse • Apr 16
Should You Investigate Stepan Company (NYSE:SCL) At US$47.60?
While Stepan Company ( NYSE:SCL ) might not have the largest market cap around , it received a lot of attention from a...Seeking Alpha • Feb 04
Stepan Company: A 'Moderate Buy' Despite A High Valuation
Summary Stepan Company, a specialty chemicals manufacturer, excels in operational efficiency and dividend growth, making it a stable investment despite current valuations. Q3 FY24 financials show margin expansion and significant net income growth, despite a 3% revenue decline, highlighting fiscal discipline. Trading at a forward P/E of 17.3x for 2025, Stepan's stock has a potential 26% upside, making it a promising investment opportunity. I am an investment analyst with a focus on income generation. Read the full article on Seeking AlphaArticle d’analyse • Jan 18
Shareholders Should Be Pleased With Stepan Company's (NYSE:SCL) Price
With a price-to-earnings (or "P/E") ratio of 31.4x Stepan Company ( NYSE:SCL ) may be sending very bearish signals at...Article d’analyse • Nov 26
These 4 Measures Indicate That Stepan (NYSE:SCL) Is Using Debt Extensively
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Article d’analyse • Nov 02
Stepan's (NYSE:SCL) Upcoming Dividend Will Be Larger Than Last Year's
The board of Stepan Company ( NYSE:SCL ) has announced that the dividend on 13th of December will be increased to...Seeking Alpha • Oct 30
Stepan Company: Not A Great Performance, But Good Value
Summary Stepan Company, despite underperformance and volatility, has long-term upside due to its unique position in the specialty chemicals market, particularly surfactants. The company's fundamentals have improved with reduced CapEx and positive FCF, but current earnings and macro pressures persist. SCL's growth potential is tied to the surfactant segment and market diversification, though the timing of earnings recovery remains uncertain. I rate Stepan as a "Buy" with a $90 PT, but caution that there are superior investments in the chemicals sector with better returns. Read the full article on Seeking Alpha
Nouveau récit • Sep 24
Calculated Supply Chain And Market Expansion Drive Robust Growth And Margin Improvement
Operational cost reductions and workforce productivity improvements aim to positively impact net margins.Article d’analyse • Aug 30
Some Investors May Be Worried About Stepan's (NYSE:SCL) Returns On Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...Article d’analyse • Aug 17
Stepan (NYSE:SCL) Takes On Some Risk With Its Use Of Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Rendement pour les actionnaires
| SCL | US Chemicals | US Marché | |
|---|---|---|---|
| 7D | 0.5% | 0.4% | -1.4% |
| 1Y | 2.0% | 2.6% | 16.4% |
Rendement vs Industrie: SCL correspondait au secteur US Chemicals qui a rapporté 2.6 % au cours de l'année écoulée.
Rendement vs marché: SCL a sous-performé le marché US qui a rapporté 16.4 % au cours de l'année écoulée.
Volatilité des prix
| SCL volatility | |
|---|---|
| SCL Average Weekly Movement | 4.0% |
| Chemicals Industry Average Movement | 6.2% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.2% |
Cours de l'action stable: SCL n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché US.
Volatilité au fil du temps: La volatilité hebdomadaire de SCL ( 4% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1932 | 2,328 | Luis Rojo | www.stepan.com |
Stepan Company, ainsi que ses filiales, produit et vend des spécialités chimiques et des produits chimiques intermédiaires à d'autres fabricants qui les utilisent dans divers produits finis aux États-Unis, en France, en Pologne, au Royaume-Uni, au Brésil, au Mexique et dans le monde entier. Elle opère à travers trois segments : Les tensioactifs, les polymères et les produits spécialisés. Le segment des surfactants propose des surfactants utilisés dans les produits de nettoyage et de désinfection grand public et industriels, notamment les détergents pour le lavage des vêtements, de la vaisselle, des tapis, des sols et des murs, ainsi que les shampooings et les gels douche, et dans d'autres applications telles que les assouplisseurs, les composés quaternaires germicides, les désinfectants, les ingrédients lubrifiants, les émulsifiants pour l'épandage de produits agricoles et les applications industrielles comprenant les systèmes de latex, les plastiques et les matériaux composites.
Stepan Company Résumé des fondamentaux
| SCL statistiques fondamentales | |
|---|---|
| Capitalisation boursière | US$1.33b |
| Bénéfices(TTM) | -US$14.22m |
| Recettes(TTM) | US$2.34b |
0.6x
Ratio P/S-94.1x
Ratio P/ELe site SCL est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| SCL compte de résultat (TTM) | |
|---|---|
| Recettes | US$2.34b |
| Coût des recettes | US$2.08b |
| Marge brute | US$259.28m |
| Autres dépenses | US$273.50m |
| Les revenus | -US$14.22m |
Derniers bénéfices déclarés
Mar 31, 2026
Prochaine date de publication des résultats
Jul 29, 2026
| Résultat par action (EPS) | -0.63 |
| Marge brute | 11.06% |
| Marge bénéficiaire nette | -0.61% |
| Ratio dettes/capitaux propres | 54.6% |
Quelles ont été les performances à long terme de SCL?
Voir les performances historiques et les comparaisonsDividendes
2.7%
Rendement actuel des dividendes-251%
Ratio de distributionAnalyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/07/22 04:04 |
| Cours de l'action en fin de journée | 2026/07/22 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Stepan Company est couverte par 4 analystes. 2 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Michael Harrison | Seaport Research Partners |
| Daniel Rizzo | Sidoti & Company, LLC |
| Vincent Anderson | Stifel, Equities Research |